CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM Trademark

Trademark Overview


On Tuesday, February 14, 2023, a trademark application was filed for CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM with the United States Patent and Trademark Office. The USPTO has given the CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM trademark a serial number of 97795022. The federal status of this trademark filing is REGISTERED as of Tuesday, August 27, 2024. This trademark is owned by Scleroderma Research Foundation. The CONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for others
conquest scleroderma research foundation clinical trial platform

General Information


Serial Number97795022
Word MarkCONQUEST SCLERODERMA RESEARCH FOUNDATION CLINICAL TRIAL PLATFORM
Filing DateTuesday, February 14, 2023
Status700 - REGISTERED
Status DateTuesday, August 27, 2024
Registration Number7484782
Registration DateTuesday, August 27, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized word "CONQUEST" in blue, with the image of three caret-shaped symbols in blue appearing above the letters "UEST" in "CONQUEST", with each caret-shaped symbol consisting of two rows of dots with the size of the dots increasing in each caret-shaped symbol going from left to right, and the stylized words "SCLERODERMA RESEARCH FOUNDATION" appearing in light blue immediately beneath the word "CONQUEST", and the stylized words "CLINICAL TRIAL PLATFORM" appearing in light blue immediately beneath the words "SCLERODERMA RESEARCH FOUNDATION".
Section 2(f) Limitation StatementAS TO "SCLERODERMA RESEARCH FOUNDATION"
Indication of Colors claimedThe colors blue and light blue are claimed as a feature of the mark.
NOT AVAILABLE"RESEARCH FOUNDATION" and "CLINICAL TRIAL PLATFORM"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, March 5, 2023
Primary Code042
First Use Anywhere DateWednesday, February 1, 2023
First Use In Commerce DateWednesday, February 1, 2023

Trademark Owner History


Party NameScleroderma Research Foundation
Party Type30 - Original Registrant
Legal Entity Type54 - NOT AVAILABLE
AddressSan Francisco, CA 94104

Party NameScleroderma Research Foundation
Party Type20 - Owner at Publication
Legal Entity Type54 - NOT AVAILABLE
AddressSan Francisco, CA 94104

Party NameScleroderma Research Foundation
Party Type10 - Original Applicant
Legal Entity Type54 - NOT AVAILABLE
AddressSan Francisco, CA 94104

Trademark Events


Event DateEvent Description
Friday, February 17, 2023NEW APPLICATION ENTERED
Sunday, March 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 7, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, November 13, 2023ASSIGNED TO EXAMINER
Monday, November 13, 2023NON-FINAL ACTION E-MAILED
Monday, November 13, 2023NON-FINAL ACTION WRITTEN
Monday, November 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 4, 2024NON-FINAL ACTION WRITTEN
Thursday, January 4, 2024NON-FINAL ACTION E-MAILED
Thursday, January 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, February 11, 2024NON-FINAL ACTION WRITTEN
Sunday, February 11, 2024NON-FINAL ACTION E-MAILED
Sunday, February 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED